
As European markets navigate a landscape marked by robust corporate earnings and geopolitical tensions, the pan-European STOXX Europe 600 Index has shown resilience with a recent uptick. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholders, potentially fostering sustainable earnings growth even amidst market volatility.
| Name | Insider Ownership | Earnings Growth |
| MilDef Group (OM:MILDEF) | 10.3% | 30.9% |
| Kuros Biosciences (SWX:KURN) | 26.1% | 61.1% |
| KebNi (OM:KEBNI B) | 11.8% | 90.9% |
| Hacksaw (OM:HACK) | 13.2% | 23.7% |
| Dellia Group (OB:DELIA) | 29.9% | 47.9% |
| CTT Systems (OM:CTT) | 17.4% | 55.3% |
| Clavister Holding AB (publ.) (OM:CLAV) | 20.5% | 73.9% |
| CD Projekt (WSE:CDR) | 35.2% | 39% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.8% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 50.2% |
Let's uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Floridienne S.A. operates in the life sciences, food, and chemistry sectors across Belgium, Europe, the Americas, and internationally with a market cap of €587.25 million.
Operations: The company generates revenue through its Food segment (€155.23 million), Recycling activities (€32.38 million), and Life Sciences Division (€538.27 million).
Insider Ownership: 15.9%
Earnings Growth Forecast: 60.6% p.a.
Floridienne shows potential for growth with earnings forecasted to increase significantly at 60.6% annually, outpacing the Belgian market's 13.6%. However, revenue growth is slower at 11.3% per year and profit margins have decreased from last year. Despite no recent insider trading activity, high insider ownership could align management interests with shareholders'. The company recently affirmed a €0.21 annual dividend per share, indicating confidence in its financial stability despite interest coverage concerns.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Elekta AB (publ) is a medical technology company that offers clinical solutions for treating cancer and brain disorders across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with a market cap of approximately SEK18.62 billion.
Operations: The company's revenue segments are comprised of SEK5.55 billion from the Asia Pacific, SEK4.46 billion from the Americas, and SEK6.71 billion from Europe, the Middle East, and Africa (EMEA).
Insider Ownership: 18.2%
Earnings Growth Forecast: 42.1% p.a.
Elekta's insider ownership aligns management interests with shareholders, supported by recent insider buying. Despite a challenging financial year with a SEK 519 million net loss and declining sales, the company forecasts revenue growth of 4.2% annually and expects profitability within three years. Trading at good value compared to peers, Elekta plans to improve its EBIT margin next fiscal year. However, high debt levels and an unsustainable dividend remain concerns amidst ongoing product recalls affecting medical device reliability.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Rusta AB (publ) operates as a retailer offering home decoration, consumables, seasonal products, leisure items, and DIY products across Sweden, Norway, Finland, and Germany with a market cap of SEK13.76 billion.
Operations: The company's revenue is derived from its operations in Sweden (SEK7.47 billion), Norway (SEK2.68 billion), and other markets (SEK2.46 billion).
Insider Ownership: 13.5%
Earnings Growth Forecast: 14.7% p.a.
Rusta's growth trajectory is underscored by strong insider ownership, aligning management with shareholder interests. The company's earnings are forecast to grow at 14.7% annually, outpacing the Swedish market. Despite a recent net loss of SEK 61 million in Q4, annual sales increased to SEK 12.60 billion. Trading at a significant discount to fair value enhances its appeal as an investment opportunity, though revenue growth remains moderate compared to high-growth benchmarks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com